Anfield Capital Management, LLC Vir Biotechnology, Inc. Transaction History

Anfield Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	SELL	$19.96 - $28.22 $2,455 - $3,471	-123 Reduced 15.57%	667 $16,000
Q3 2022 Nov 09, 2022	BUY	$18.26 - $31.1 $511 - $870	28 Added 3.67%	790 $15,000
Q2 2022 Aug 09, 2022	BUY	$19.08 - $26.7 $2,136 - $2,990	112 Added 17.23%	762 $19,000
Q1 2022 May 13, 2022	BUY	$21.19 - $40.01 $13,773 - $26,006	650 New	650 $17,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Anfield Capital Management, LLC with notifications on news.